What is new? • Few small population/rare disease trials are using Bayesian methods and those that don't are ending up under sized and underpowered. • Researchers in rare disease and small population trials should be striving to use Bayesian methods where possible or follow recommendations suggested by Parmar et al. (2016) Abstract Objective : Frequentist trials in Rare disease/small population trials often require unfeasibly large sample size to detect minimum clinically important differences.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile